• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. XIENCE SKYPOINT¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. XIENCE SKYPOINT¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 1804275-48
Medical Device Problem Code Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/20/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the procedure performed was to treat mildly tortuous mid and distal circumflex arteries of the left circumflex coronary artery.After implantation of a 2.75x48mm xience skypoint drug-eluting stent, the stent was noted to be expired.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.H6: medical device problem code 2017 - use after expiration.
 
Additional Manufacturer Narrative
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other similar complaints from this lot.Reportedly, the xience skypoint was used past the expiration date.The xience skypoint everolimus eluting coronary stent system instructions for use states: do not use after the use by date.The incident information was reviewed; however, the product was not returned to abbott vascular for analysis.The expiration date of the product is important for sterility, efficacy, and performance of the device.Per the xience use failure mode effect analysis, potentially adverse events of using the device post expiration date include fever and stenosis/restenosis.However, in this case there was no reported device failures or patient adverse events reported.Based on the information received, the investigation determined that the reported complaint appears to be related to user error.The expiration date of the product is important for sterility, efficacy, and performance of the device.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT¿
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key20905742
Report Number2024168-2024-14551
Device Sequence Number14454964
Product Code NIQ
UDI-Device Identifier08717648231278
UDI-Public(01)08717648231278(17)241112(10)3111741
Combination Product (Y/N)Y
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/15/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/12/2024
Device Model Number1804275-48
Device Catalogue Number1804275-48
Device Lot Number3111741
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/20/2024
Supplement Date Received by Manufacturer01/13/2025
Initial Report FDA Received Date12/11/2024
Supplement Report FDA Received Date01/15/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/13/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age60 YR
Patient SexMale
Patient Weight93 KG
-
-